Skip to main content
Fig. 10 | Fluids and Barriers of the CNS

Fig. 10

From: Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B

Fig. 10

Salivary levels in control or after BBB disruption. Note the delayed progression of salivary S100B towards steady state. Swallowing of saliva was not modeled for clarity and because nothing is known about the half-life of S100B in saliva. See refs. [2, 32, 33]. Saliva production was modeled at 4 and 2 ml/min

Back to article page